
Animal Protective League rescues 72 animals
APL Shelter Director Diane King said the tip brought them to a property in Ashtabula, where they recovered 44 animals May 15.
The APL and its humane officer was assisted by the Ashtabula Police Department's animal control officer, King said.
The county humane agent works with the APL and has the authority to enforce provisions of the Ohio Revised Code relating to animal cases.
King said they got a tip the property owner had a second home outside the city, which they responded to May 27.
'We removed another 28 animals,' she said.
King said she could say where the second property was located.
The 72 rescued animals consisted of 69 cats and three dogs.
'We are trying to work with other shelters, rescues, anybody that's able to pull animals from us at this time would be helpful,' she said.
King has been the shelter director for around a month, she said.
'I've been involved with working with animals for 25 years,' she said. 'I came from Trumbull County as the Chief Humane Officer and Program and Outreach Director. So, I have a pretty extensive background in animal care, and cruelty and neglect [cases].'
King described the conditions she saw during the recent rescue.
'Entering a home like that, it's difficult to navigate,' she said. 'It was dark and you're hit with an overwhelming smell of fecal ammonia. Your eyes burn. Your throat burns. We had to wear respirators. You're walking on uneven ground, because there's several inches of urine and feces caked throughout the entire home.'
King said the floor was squishy beneath her feet because of all the urine and feces.
Animal hoarding houses have a distinct and overwhelming smell, she said.
'You typically see a lot of flies outside,' she said. 'You can smell it on the front porch.'
King said Ohio residents who want to leave a tip about a property they suspect of hoarding animals can reach out to the county humane society.
'A lot of cat hoarding cases, sometimes it's due to mental illness, but other times it's due to a population explosion,' she said. 'It's very important that you spay and neuter your animals.'
People can learn about mobile clinics available through petfix.com and rascalunit.com.
'They are traveling [spay and neuter] clinics,' she said. 'They're able to look up different dates and locations.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
Is it Time to Sell UnitedHealth Group (UNH) Before its Too Late?
Parnassus Investments, an investment management firm that focuses on owning a concentrated portfolio of U.S. large cap stocks, released its Parnassus Value Equity Fund second-quarter 2025 investor letter. The full letter is available for download here. For the second quarter of 2025, the fund reported a net return of 7.24%, outperforming its benchmark, the Russell 1000 Value Index, which returned 3.79% for the same period. The fund's top 5 holdings are also listed in the letter, showing the firm's main investment positions heading into 2025. One of the companies mentioned in the letter is UnitedHealth Group Inc. (NYSE:UNH). UnitedHealth Group Inc. (NYSE:UNH) operates as a health care company in the United States and internationally. Over the past month, UnitedHealth Group Inc. (NYSE:UNH) fell by -15.12%, and it went down to -54.69% over the last 12 months. On July 29, 2025, UnitedHealth Group Inc. (NYSE:UNH) shares closed at $261.07, with a market value of $236.83 billion. Here is what they have to say about UnitedHealth Group Inc. (NYSE:UNH) in their investor letter: "UnitedHealth Group declined as the company battled with the fallout of missing earnings forecasts and the abrupt resignation of Chief Executive Andrew Witty. We are optimistic that execution will significantly improve with the return of former CEO Stephen Hemsley." Is it Time to Sell UnitedHealth Group (UNH) Before its Too Late? UnitedHealth Group Inc. (NYSE:UNH) ranks 18th in our list of the 30 most popular stocks among hedge funds. According to our data, 139 hedge fund portfolios held positions in UnitedHealth Group Inc. (NYSE:UNH) at the end of the first quarter of 2025, down from 150 in the previous quarter. While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. UnitedHealth Group Inc. (NYSE:UNH) ranks 18th in our list of the 30 most popular stocks among hedge funds. According to our data, 139 hedge fund portfolios held positions in UnitedHealth Group Inc. (NYSE:UNH) at the end of the first quarter of 2025, down from 150 in the previous quarter. While we acknowledge the risk and potential of UNH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than UNH and that has 10,000% upside potential, check out our report about this cheapest AI stock. In another article, we covered UnitedHealth Group Inc. (NYSE:UNH) and Barclays analyst Andrew Mok's views on the company in the previous quarter. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
22 minutes ago
- Yahoo
Candel Therapeutics to Present at the Canaccord Genuity 45th Annual Growth Conference
NEEDHAM, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced that Paul Peter Tak, M.D., Ph.D., FMedSci, Candel's President and Chief Executive Officer, will present at the Canaccord Genuity 45th Annual Growth Conference, being held on August 12-14, 2025 in Boston, MA. Date: Wednesday, August 13, 2025Time: 2:00-2:25PM ESTWebcast Link: Canaccord Genuity / Candel Presentation A webcast of the presentation will be available by selecting Events and Presentations under the News & Events tab in the Investors section on A replay of the webcast will be archived for up to 90 days following the session date. About Candel Therapeutics Candel is a clinical-stage biopharmaceutical company focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. Candel has established two clinical-stage multimodal biological immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) gene constructs, respectively. CAN-2409 is the lead product candidate from the adenovirus platform. The Company recently completed successful phase 2a clinical trials of CAN-2409 in non-small cell lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC), and a pivotal, placebo-controlled phase 3 clinical trial of CAN-2409 in localized prostate cancer, conducted under a Special Protocol Assessment (SPA) agreed with the U.S. Food and Drug Administration (FDA). In May 2025, the FDA granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CAN-2409 for the treatment of newly diagnosed localized prostate cancer in patients with intermediate-to-high-risk disease. CAN-3110 is the lead product candidate from the HSV platform and is currently in an ongoing phase 1b clinical trial in recurrent high-grade glioma (rHGG). Initial results were published in Nature and CAN-3110 received Fast Track Designation and Orphan Drug Designation from the FDA. Finally, Candel's enLIGHTEN™ Discovery Platform is a systematic, iterative HSV-based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapies for solid tumors. For more information about Candel, visit: Forward-Looking Statements This press release includes certain disclosures that contain 'forward-looking statements,' within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, express or implied statements regarding the timing and advancement of current and future development programs; expectations regarding the therapeutic benefit of the Company's platforms; and expectations regarding the potential benefits conferred by Regenerative Medicine Advanced Therapy Designation, Fast Track Designation, Orphan Drug Designation or Orphan Designation. The words 'may,' 'will,' 'could,' 'would,' 'should,' 'expect,' 'plan,' 'anticipate,' 'intend,' 'believe,' 'estimate,' 'predict,' 'project,' 'potential,' 'continue,' 'target' and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements in this press release are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward-looking statements contained in this press release, including, without limitation, those risks and uncertainties related to the timing and advancement of development programs; expectations regarding the therapeutic benefit of the Company's programs; that final data from the Company's preclinical studies and completed clinical trials may differ materially from reported interim data from ongoing studies and trials; the Company's ability to efficiently discover and develop product candidates; the Company's ability to obtain and maintain regulatory approval of product candidates; the Company's ability to maintain its intellectual property; the implementation of the Company's business model, including strategic plans for the Company's business and product candidates; and other risks identified in the Company's filings with the U.S. Securities and Exchange Commission (SEC), including the Company's most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, each as filed with the SEC and any subsequent filings with the SEC. The Company cautions you not to place undue reliance on any forward-looking statements, which speak only as of the date they are made. The Company disclaims any obligation to publicly update or revise any such statements to reflect any change in expectations or in events, conditions, or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements. Any forward-looking statements contained in this press release represent the Company's views only as of the date hereof and should not be relied upon as representing its views as of any subsequent date. Investor ContactTheodore JenkinsVice President, Investor Relations and Business DevelopmentCandel Therapeutics, Media ContactBen ShannonVice PresidentICR Healthcare CandelPR@ produjo un error al recuperar la información Inicia sesión para acceder a tu portafolio Se produjo un error al recuperar la información Se produjo un error al recuperar la información Se produjo un error al recuperar la información Se produjo un error al recuperar la información


CNET
23 minutes ago
- CNET
Stop Taking So Long to Reply to Texts. You're Sabotaging Your Friendships
Depending on who you ask, texting is either an easy way to keep in touch or an overbearing item on an ever-growing to-do list. What's convenient for one person may be a burden to another, which can cause strains on some relationships. So, how long can someone go without texting you back before they end up on the friendship chopping block? Not very long, if you ask me. It might come across as harsh, but I believe healthy relationships are sustained by timely communication, instead of consistently leaving someone on Read or Delivered for a week. It becomes practically impossible to coordinate hangouts or share life updates if someone can't bother to respond to your messages within a reasonable window, or otherwise call you if that's how they prefer to chat. Friends who take days to reply -- if they ever do -- come off as indifferent and uninterested, especially when they don't arrange alternative ways to catch up. You might start to wonder how much they actually value your time and effort, and why they don't prioritize communicating with you. Repeated offenses can make it tempting to throw in the towel and invest your energy elsewhere. How long can you go without texting someone back? I'll first acknowledge my personal bias here: I have always enjoyed texting. It's been my preferred method of communication since I got my first phone at 13 years old and discovered the magic of talking to my friends anytime, anywhere. It's no coincidence that some of my closest friends tend to be people with whom I regularly text. There's a sense of familiarity that comes from sharing your day-to-day experiences and thoughts. It's also a fun way to engage in banter and share relatable memes and videos. And before I upset anyone -- if I haven't already -- I'll again acknowledge that for some people, texting isn't enjoyable. But I still think people have a responsibility to communicate clearly and frequently with loved ones if they hope to maintain those relationships, whether it's a text, phone call or in-person meetup. So, what's an acceptable window of time for someone to text you back? Despite how unaccommodating I may come off in that frank introduction, I do like to give people chances. If someone takes days to reply to me the first time, or simply never gets back to me, I let it go. But if it happens again, that's a strike. I believe you should always text someone back within a 24-hour period -- notwithstanding special circumstances like travel or illness, etc. Repeatedly taking several days to reply is not only inconsiderate, it also just kills the vibe. Why do I care if you laughed at a meme I sent you five days ago? At that point, I won't even remember what I reached out to you about. And if I'm asking you about going to an event and you only respond after it's over, that unlocks a whole other level of annoyance. I believe the time and effort you invest in friendships includes replying to texts within a reasonable period (as long as your friend isn't bombarding your inbox, of course). So if someone continuously takes days to reply, I take it as my sign to stop trying, and to put that energy into the friends who won't leave me waiting. A more personal way to stay in touch As a teenager, my friends and I would text each other around the clock, sending a steady stream of messages and photos about anything and everything, most of it totally inconsequential. (Being young and unemployed made this all the easier.) But as we got older and busier, and as social media began eating up our free time, text messages were largely supplanted by posting and consuming content on platforms like Facebook and Instagram. Our digital activity became less personal, more performative and less conducive to maintaining relationships. Social media gives the false impression of keeping up with someone without actually talking to them, so relationships tend to fracture. Most people have witnessed the awkwardness of someone not replying to your text for days, but ceaselessly posting on social media. Time and energy goes into both activities, and choosing to bypass personal interactions for more public-facing ones can prevent you from feeling a genuine connection to the people who care to reach out to you. Taking 30 seconds to reply to a text could be the difference between making and breaking a meaningful relationship. While phone calls and in-person meetups are undoubtedly the best ways to have an in-depth conversation with someone, finding a time that works for both parties can be a challenge, given how increasingly hectic our lives have become. Texting can be a comparatively low-lift way to build a true sense of camaraderie and connection. So, the next time you think it's not a big deal to leave someone on Read or Delivered, maybe reconsider what your actions (or lack thereof) may convey.